CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

AstraZeneca Pharma India Ltd.

NSE : ASTRAZENEQ BSE : 506820 ISIN CODE : INE203A01020Industry : Pharmaceuticals

News

  • AstraZeneca Pharma I - General Updates 11 Mar 2026 | 16:39 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Shareholders meeting 27 Feb 2026 | 16:56 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange regarding Notice of Postal Ballotmore...

  • AstraZeneca Pharma I - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 27 Feb 2026 | 16:41 | Dion Global

    Please find the enclosed Postal Ballot Notice dated February 11 2026 for your reference.more...

  • AstraZeneca Pharma I - Copy of Newspaper Publication 19 Feb 2026 | 18:22 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • AstraZeneca Pharma I - Certificate under SEBI (Depositories and Participants) Regulations, 2018 19 Feb 2026 | 18:04 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • AstraZeneca Pharma I - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 19 Feb 2026 | 18:02 | Dion Global

    Please find the enclosed certificate of the Company in relation to the captioned subject for your reference.more...

  • AstraZeneca Pharma I - General Updates 18 Feb 2026 | 15:33 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I Q3 net profit up 5.64% at Rs 32.59 cr 11 Feb 2026 | 19:30 | Dion Global

    The company reported standalone net profit of Rs 32.59 crore for the quarter ended December 31 2025 as compared to Rs 30.85 crore in the sam...more...

  • AstraZeneca Pharma I - Outcome of Board Meeting 11 Feb 2026 | 19:05 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11 2026.more...

  • AstraZeneca Pharma I - Outcome Of The Board Meeting Held On Wednesday, February 11, 2026 11 Feb 2026 | 19:00 | Dion Global

    Please find the enclosed financials of the Company for the quarter ended December 31 2025 for your reference.more...

  • AstraZeneca Pharma I - General Updates 11 Feb 2026 | 17:51 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Appointment of Company Secretary and Compliance Officer 11 Feb 2026 | 17:45 | Dion Global

    Please find the enclosed letter of the Company as per the captioned subject for your reference.more...

  • AstraZeneca gets CDSCO approval for Imfinzi in additional cancer indication 10 Feb 2026 | 14:35 | Dion Global

    AstraZeneca Pharma India Ltd on Tuesday said it has received regulatory approval from India s drug regulator to market its cancer therapy Imfinzi for...more...

  • AstraZeneca Pharma I - General Updates 10 Feb 2026 | 10:57 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 10 Feb 2026 | 10:53 | Dion Global

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.more...

  • AstraZeneca Pharma India Ltd receives Central Drugs Standard Control 04 Feb 2026 | 16:05 | Dion Global

    Organisation nod for Durvalumab in gastric cancer therapy AstraZeneca Pharma India Ltd has secured approval from the Central Drugs Standard ...more...

  • AstraZeneca Pharma I - General Updates 02 Feb 2026 | 18:15 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - General Updates 31 Jan 2026 | 13:44 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 31 Jan 2026 | 13:42 | Dion Global

    Please find the enclosed letter of the Company in relation to the captioned subject for your reference.more...

  • AstraZeneca Pharma I - Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results Of The Compan 31 Jan 2026 | 13:38 | Dion Global

    Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74563.92-1.93%
NSE Index23151.1-2.06%
B500DIVL503456.14-2.58%
BSE 1000 9930.73-2.32%
BSE 100LCTMC8618.83-2.15%
BSE Auto 53876.79-3.27%

Commodity

Gold157863-1.22%
Silver258071-3.92%
Copper1235.1202.87%
Crude Oil884137.86%
Lead197.647.02%
Mentha Oil1063.9-0.33%
Nickel1635.5113.26%

Currency

USD/INR 92.26(0.62 %)
GBP/INR 122.91(0.34 %)
EUR/INR 106.59(0.16 %)
JPY/INR 0.58(-0.13 %)
CAD/INR 67.91(0.56 %)
HKD/INR 11.80(0.67 %)